Allogene Therapeutics ALLO
NASDAQ ALLO
$1.62 -0.01 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Total Liabilities (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) posted Total Liabilities of $113.92 million for Q2 2026, down 9.6% from $126.03 million a year earlier and down 2.7% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Total Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Allogene Therapeutics' Total Liabilities came in at $123.36 million, down 2.5% from FY2024.

  • Annual Total Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -10.5% (FY2020 to FY2025).
  • In prior years, Allogene Therapeutics' Total Liabilities was $126.53 million in FY2024 (-3.1%), $130.6 million in FY2023 (-15.6%), $154.7 million in FY2022 (+23.1%) and $125.63 million in FY2021 (-41.4%).
  • The Q2 2026 figure stands as the lowest quarterly Total Liabilities since Q1 2022.
  • On a year-over-year basis, Total Liabilities has declined in each of the last 12 quarters, with an average decline of 4.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Liabilities in the past five years was Q2 2022, with growth of 44.9%; the weakest was Q4 2021, with a decline of 41.4%.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $117.08 million (Q1 2026), $123.36 million (Q4 2025) and $124.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Allogene Therapeutics 562.91 Mn 562.91 Mn - 113.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 113.92 Mn
Mar 31, 2026 117.08 Mn
Dec 31, 2025 123.36 Mn
Sep 30, 2025 124.44 Mn
Jun 30, 2025 126.03 Mn
Mar 31, 2025 122.59 Mn
Dec 31, 2024 126.53 Mn
Sep 30, 2024 125.37 Mn
Jun 30, 2024 131.85 Mn
Mar 31, 2024 124.98 Mn
Dec 31, 2023 130.60 Mn
Sep 30, 2023 132.78 Mn
Jun 30, 2023 151.60 Mn
Mar 31, 2023 158.12 Mn
Dec 31, 2022 154.70 Mn
Sep 30, 2022 151.08 Mn
Jun 30, 2022 149.14 Mn
Mar 31, 2022 112.82 Mn
Dec 31, 2021 125.63 Mn
Sep 30, 2021 109.30 Mn
API Access

Allogene Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ALLO&period=max&api_key=YOUR_API_KEY